The company is a leading contract research manufacturing services (CRAMS) focused speciality chemical manufacturer. It majorly manufactures chemicals that are import substitutes, like complex chemicals from heterocyclic and fluoro chemical products, which were primarily imported from China. The speciality chemicals produced by the company are sold domestically to various industries.
Survival Technologies Ltd. engages with customers across product lifecycles, including in-house R&D, commercial scale process development, and commercial manufacturing speciality items. Between April 1, 2007 and March 31, 2022, it has synthesised 677 products, including 500 products commercially produced for the export market.
It has three manufacturing units, two of which are in Gujarat.
Survival Technologies Ltd. IPO Details
Survival Technologies Ltd. has filed DRHP to raise Rs. 1000 crore from investors. The IPO includes fresh equities worth Rs. 200 crores and an offer for sale of Rs. 800 crore equities from the existing promoters.
Survival Technologies Ltd. IPO will open in FY24. We will update the dates once declared.
Survival Technologies Ltd. IPO Objective
The company proposes to utilise the net proceeds received from the fresh issues in the following areas.
- Funding working capital requirements
- General corporate purposes
Should you invest in Survival Technologies Ltd.?
You may like to consider the following reasons before investing in Survival Technologies Ltd. IPO.
- The company offers a diversified product suite backed by strong R&D.
- It’s one of the leading Indian CRAMS companies in manufacturing certain specialised chemicals in FY22.
- The nature of the industry where the company operates is constrained by a high entry barrier, which prevents extensive barriers.
Competitive Peers
Other players in the domain as recognised by Survival Technologies Ltd. are Alkyl Amines Chemical Ltd., Neogen Chemicals Ltd., Aether Industries Ltd., and Navin Fluorine International Ltd.
Survival Technologies Ltd. Noteworthy highlights
- The company’s >50% revenue comes from CRAMS activities. The remaining comes from custom manufacturing specialised chemicals.
- Survival Technologies has recorded a 25.1% CAGR in revenue from FY20 to FY22.
- The company’s gross profit grew from Rs.831 million to Rs. 1,616 million, a CAGR of 39%.
IPO Financials
| Particulars | Year ending on March 31, 2022 | Year ending on March 31, 2021 |
|---|---|---|
| Revenue from Operations | 3,117.8 | 2,747.9 |
| Profit After Tax (PAT) | 734.6 | 563.2 |
| PAT Margin | 23.56% | 20.50% |
| EBITDA | 919.0 | 696.5 |
| EBITDA Margin | 29.48% | 25.35% |
| ROE | 32.6% | 37.0% |
Know before investing
Strengths
3The company undertakes CRAMS projects for research & development and manufacturing products for export and domestic markets.
It has a deep-industry knowledge to handle complex chemistry with a proven track record.
It’s one of the most profitable speciality chemicals manufacturing companies in India during Fiscal 2022.
Risks
3Any deterioration in customer relationships can adversely impact financial and operational performance.
The company must obtain and renew its licence periodically to continue business operations.
The investors must appraise themselves of any valuation risk of the company before buying the IPO.
